Literature DB >> 1155924

Comparative synergistic activity of nafcillin, oxacillin, and methicillin in combination with gentamicin against.

R H Glew, R S Millering, C Wennersten.   

Abstract

The effectiveness of three semisynthetic, penicillinase-resistant penicillins alone and in combination with gentamicin was tested against 29 clinical isolates of enterococci. The minimal inhibitory concentrations of nafcillin were considerably lower than those of oxacillin and methicillin but were slightly higher than those of penicillin. At clinically achievable concentrations, the combination of nafcillin plus gentamicin produced enhanced killing against 13 of 14 strains of enterococci and was synergistic (by very rigid criteria) against 10 of 14 strains. In contrast, combinations of oxacillin plus gentamicin were synergistic against only 3 of 14 strains, and methicillin plus gentamicin produced synergistic killing against only 1 of 14 strains.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1155924      PMCID: PMC429234          DOI: 10.1128/AAC.7.6.828

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Use of autoclaved extracts of hemolytic streptococci for serological grouping.

Authors:  L A RANTZ; E RANDALL
Journal:  Stanford Med Bull       Date:  1955-05

2.  Antibiotic synergism and antagonism; an assessment of the problem.

Authors:  E JAWETZ; J B GUNNISON
Journal:  Pharmacol Rev       Date:  1953-06       Impact factor: 25.468

3.  The Combined Action of Penicillin with Streptomycin or Chloromycetin on Enterococci in Vitro.

Authors:  E Jawetz; J B Gunnison; V R Coleman
Journal:  Science       Date:  1950-03-10       Impact factor: 47.728

4.  Treatment of enterococcal endocarditis and bacteremia; results of combined therapy with penicillin and streptomycin.

Authors:  W C ROBBINS; R TOMPSETT
Journal:  Am J Med       Date:  1951-03       Impact factor: 4.965

5.  Penicillin and gentamicin therapy for enterococcal infections.

Authors:  A J Weinstein; R C Moellering
Journal:  JAMA       Date:  1973-02-26       Impact factor: 56.272

6.  Enterococcal endocarditis. An analysis of 38 patients observed at the New York Hospital-Cornell Medical Center.

Authors:  G L Mandell; D Kaye; M E Levison; E W Hook
Journal:  Arch Intern Med       Date:  1970-02

Review 7.  Treatment of infective endocarditis--1973.

Authors:  L Weinstein; J Schlesinger
Journal:  Prog Cardiovasc Dis       Date:  1973 Nov-Dec       Impact factor: 8.194

8.  Penicillin-streptomycin treatment of enterococcal endocarditis. A re-evaluation.

Authors:  E Jawetz; M Sonne
Journal:  N Engl J Med       Date:  1966-03-31       Impact factor: 91.245

9.  Comparison of several laboratory media for presumptive identification of enterococci and group D streptococci.

Authors:  R R Facklam
Journal:  Appl Microbiol       Date:  1973-08

10.  Discrepancy between carbenicillin and ampicillin activities against enterococci and Listeria.

Authors:  G H McCracken; J D Nelson; M L Thomas
Journal:  Antimicrob Agents Chemother       Date:  1973-03       Impact factor: 5.191

View more
  11 in total

1.  Synergism of oxacillin and gentamicin against enterococci.

Authors:  R L Marier; N Joyce; V T Andriole
Journal:  Antimicrob Agents Chemother       Date:  1975-11       Impact factor: 5.191

2.  In vitro activity of SK&F 104662, a new glycopeptide antibiotic.

Authors:  J D Yao; G M Eliopoulos; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

3.  Synergism of cefazolin-gentamicin against enterococci.

Authors:  M Bourque; R Quintiliani; R C Tilton
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

4.  Synergy of combinations of vancomycin, gentamicin, and rifampin against methicillin-resistant, coagulase-negative staphylococci.

Authors:  F D Lowy; D S Chang; P R Lash
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

5.  Penicillinase-resistant penicillins plus gentamicin in experimental enterococcal endocarditis.

Authors:  L J Lincoln; A J Weinstein; M Gallagher; E Abrutyn
Journal:  Antimicrob Agents Chemother       Date:  1977-10       Impact factor: 5.191

6.  Synergy in the antimicrobial action of penicillin and beta-chloro-D-alanine in vitro.

Authors:  T S Soper; J M Manning
Journal:  Antimicrob Agents Chemother       Date:  1976-02       Impact factor: 5.191

7.  Efficacy of teicoplanin in two dosage regimens for experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin.

Authors:  J D Yao; C Thauvin-Eliopoulos; G M Eliopoulos; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

8.  Comparative in vitro activity of nafcillin, oxacillin, and methicillin in combination with gentamicin and tobramycin against enterococci.

Authors:  C Watanakunakorn; C Glotzbecker
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

9.  Effect of protein binding on the activity of penicillins in combination with gentamicin against enterococci.

Authors:  R H Glew; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1979-01       Impact factor: 5.191

10.  Unusually high occurrence of drug reactions with nafcillin.

Authors:  B Zakhireh; R K Root
Journal:  Yale J Biol Med       Date:  1978 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.